Business Insider11h
Wolfe starts ‘best-in-class’ Tempus AI with an Outperform
As previously reported, Wolfe Research analyst Doug Schenkel initiated coverage of Tempus AI (TEM) with an Outperform rating and $60 price target Tempus AI, a diagnostic company that has built a ...
General Dynamics downgraded at Wolfe Research
General Dynamics (GD) downgraded to Peer Perform from Outperform by Wolfe Research due to challenges in Gulfstream unit and shipbuilding operations.
Nasdaq28d
Wolfe Research starts Regeneron at Outperform, sees ‘attractive entry point’
Wolfe Research initiated coverage of Regeneron (REGN) with an Outperform rating and $1,150 price target Eylea patent litigation concerns had pressured Regeneron from all-time highs, and the firm ...
GE Vernova stock 'has been a home run' but Wolfe Research still sees value
Additionally, Wolfe sees potential for "significant capital return" given GE Vernova's strong balance sheet, which includes ...
Wolfe’s short ideas: Companies with potential dividend cuts
Wolfe Research analysts listed stocks with potential dividend cuts as part of its “short screen stock ideas” report.
Morningstar10d
McGrath to Participate in the Wolfe Research Small and Mid-Cap Conference
will participate in investor meetings at the Wolfe Research Small and Mid-Cap Conference on Thursday, December 5, 2024. Core CPI was at a 3.3% annual rate, in line with forecasts. After spending ...
Wolfe Research为Stevanato股票设定目标价，看好增长前景
周五，Wolfe Research对市值61.6亿美元的Stevanato Group S.p.A.（纽交所代码：STVN）股票启动跟踪，给予"跑赢大市"评级，目标价为28.00美元。该机构强调，公司有潜力从目前3.53%的增速恢复到两位数的收入增长，因为它为生物制药行业提供关键组件和解决方案。根据InvestingPro数据，分析师对该股票的目标价区间为21美元至37美元。
TipRanks on MSN6h
Hologic initiated with a Peer Perform at Wolfe Research
Wolfe Research initiated coverage of Hologic (HOLX) with a Peer Perform rating.Pick the best stocks and maximize your ...